Showing results (141-150 of 686) with videos related to
Sort By:
Pageof 69
International Journal of Chronic Obstructive Pulmonary Disease|June 27, 2014
Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2-4 COPD: results from two replicate 48-week studiesGary T Ferguson, Gregory J Feldman, Peter Hofbauer, et al.Journal of Aerosol Medicine and Pulmonary Drug Delivery|November 21, 2018
Satisfaction with the Use of eFlow Closed-System Nebulizer in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: Findings from a Long-Term Safety StudyEdward M Kerwin, James F Donohue, Gary T Ferguson, et al.NPJ Primary Care Respiratory Medicine|February 4, 2017
Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studiesGary T Ferguson, Jill Karpel, Nathan Bennett, et al.Chest|April 20, 1999
The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPDP M Dorinsky, C Reisner, G T Ferguson, et al.Cancer Research|October 5, 2001
Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cellsX Yang, D L Phillips, A T Ferguson, et al.International Journal of Chronic Obstructive Pulmonary Disease|January 19, 2019
Effects of baseline symptom burden on treatment response in COPDFernando J Martinez, Roger A Abrahams, Gary T Ferguson, et al.Anticancer Research|December 1, 2021
Effect of Diallyl Trisulfide on TNF-α-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer CellsKonan J W Kanga, Patricia Mendonca, Karam F A Soliman, et al.Respiratory Medicine|April 7, 2020
Goals of COPD treatment: Focus on symptoms and exacerbationsClaus F Vogelmeier, Miguel Román-Rodríguez, Dave Singh, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 2022
Discrete roles of Ir76b ionotropic coreceptor impact olfaction, blood feeding, and mating in the malaria vector mosquito Anopheles coluzziiZi Ye, Feng Liu, Huahua Sun, et al.Respiratory Medicine|January 21, 2023
Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary diseaseJames F Donohue, Gary T Ferguson, Jill A Ohar, et al.Pageof 69